Adding MPO into the traditional risk factors that include LAV significantly increased the predictive performance for AF recurrence, suggesting the possibility of unexplored mechanisms behind the role of MPO in adverse outcomes after catheter ablation, besides the common factors shared with LAV enlargement. This evidence concerns the gene MPO and atrial fibrillation.